NCT06549335 2024-10-15Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL)Ruijin HospitalPhase 2 Not yet recruiting66 enrolled